Use of α-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation

Blood

Volumn 90, Issue 7, 1997, Pages 2549-2554

  Higano, Celestia S ^a,b   Chielens, Deborah ^a   Raskind, Wendy ^a   Bryant, Eileen ^a   Flowers, Mary E D ^a   Radich, Jerald ^a   Clift, Reginald ^a   Appelbaum, Frederick ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADOLESCENT; ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG USE; FEMALE; HUMAN; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030757710     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.7.2549     Document Type: Article

References (22)

1. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffin R, Ramberg R, Sanders JE, Singer JW, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Inten Med 104:155, 1986
2. Bilhou-Nabera C, Bernard P, Marit G, Viard F, Gharbi MJ, Wen Z, Lacombe F, Broustet A, Reiffers J: Serial cytogenetic studies in allografted patients with chronic myeloid leukemia. Bone Marrow Transplant 9:263, 1992
3. Higano CS, Raskind WH, Singer JW: Use of alpha interferon for treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation. Blood 80:1437, 1992
4. Clift R, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with buslufan and cyclophosphamide. Blood 84:2036, 1994
5. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan, Witherspoon R, Yee G, Thomas ED: Methrotexate and cyclosporine comapred with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
6. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED: Analysis of the origin of marrow cells in bone marrow transplantation recipients using a Y chromosome specific in situ hybridization assay. Blood 72:2220, 1989
7. Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P, Schoch G, Buckner CD, Sullivan KM, Appelbaum FR, Thomas ED: Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implication in 346 patients. Blood 85:2632, 1995
8. Newland AC, Jones L, Mir N, Slocombe GW: Alpha 2 interferon in chronic myeloid leukemia following relapse post-allogeneic transplant. Br J Haematol 66:141, 1987
9. Arcese W, Mauro FR, Screni M, Alimena G, Lo-Coco F, Lori AP, de Cuia MR, Montefusco E, Mandelli F: Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 5:309 1990
10. Pigneux A, Devergie A, Pochitaloff M, Rio B, Archimbaud E, Cahn JY, Leblond V, Michallet M, Jouet JP, Guilot F, Gluckman E, Reiffers J: Recombinant alpha interferon for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: A report from the Société Francaise de Greffe de Moelle, Bone Marrow Transplant 15:819 1995
11. Kolb HJ, Mittermüller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462, 1990
12. Drobyski WR, Roth MS, Thibodeau SN, Gottschall JL: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after bone marrow transplantation. Bone Marrow Transplant 10:301, 1992
13. Cullis JO, Jiang YZ, Schwarer AP, Hughes TP, Barrett AJ, Goldman JM: Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation. Blood 79:1379, 1992
14. Bär BMAM, Schattenberg A, Mensink EJ, Geurts-Van Kessel A, Smetsers TF, Knops GH, Linders EH, DeWitte T: Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 11:513, 1993
15. Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM: Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose. Blood 82:2310, 1993
16. Jiang YZ, Cullis JO, Kanter EJ, Goldman JM, Barrett AJ: T cell and NK cell mediated graft versus leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic leukemia. Bone Marrow Transplant 11:133 1993
17. Helg C, Roux E, Beris P, Cabrol C, Wacker P, Darbellay R, Wyss M, Jeannet M, Chaupis B, Roosnek E: Adoptive immunotherapy for recurrent chronic myelogenous leukemia after bone marrow transplantation. Bone Marrow Transplant 12:125, 1993
18. Hertenstein B, Wiesneth M, Novotny J, Bunjes D, Stefanic M, Heinze B, Hubner G, Hempel H, Arnold R: Interferon-a and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantion. Transplantation 56:1114, 1993
19. Leber B, Walker IR, Rodriguez A, McBride JA, Carter R, Brain MC: Reinduction of remission of chronic myelogenous leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation. Bone Marrow Transplant 12:405, 1993
20. van Rhee F, Lin F, Cullis JO, Spencer A, Cross NCP, Chase A, Garicochea B, Bungey J, Barrett J, Goldman JM: Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:337, 1994
21. Porter DL, Roth MS, McGarigle C, Ferrara JLM, Antin JH: Induction of graft verus host disease as immunotherapy for relapsed chronic myelogenous leukemia. N Engl J Med 330:100, 1994
22. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Hugo C, Barrett HC, Gillio AP, Kernan NA, Small TN, Young JW, O'Reilly RJ: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia from graft-versus-host disease. Blood 86: 1261, 1995